Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress
Abstract Chimeric antigen receptor (CAR)-T cell therapy has emerged as one of the most rapidly evolving modalities of immunotherapy, with substantial success in the treatment of hematological malignancies and encouraging outcomes in solid tumors. Yet, the efficacy of CAR-T therapy is hindered by cha...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMC
2024-12-01
|
| Σειρά: | Journal of Hematology & Oncology |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.1186/s13045-024-01639-1 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|